Cell Signaling Technology

Human BMP-2 Recombinant Protein

#4697 · $323

100
Citing papers
12.1k
Combined citations
Supplier page Find this product

Research areas

Cancer, Hypoxia, and Metabolism9Alzheimer's disease research and treatments7Colorectal Cancer Treatments and Studies6RNA modifications and cancer6Cancer-related molecular mechanisms research6interferon and immune responses5Caveolin-1 and cellular processes5Immune cells in cancer5

Papers citing this product

1
ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair
Nature Neuroscience·2019·673 cit.·DOI
2
Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer’s Disease Phenotypes
PLoS ONE·2016·573 cit.·DOI
3
Antiparallel β-sheet: a signature structure of the oligomeric amyloid β-peptide
Biochemical Journal·2009·502 cit.·DOI
4
Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammation
Journal of Clinical Investigation·2010·447 cit.·DOI
5
Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB
Biochemical Journal·2006·434 cit.·DOI
6
Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein
Journal of Neuroscience·2010·406 cit.·DOI
7
Leptin Action in the Dorsomedial Hypothalamus Increases Sympathetic Tone to Brown Adipose Tissue in Spite of Systemic Leptin Resistance
Journal of Neuroscience·2011·312 cit.·DOI
8
SERCA pump activity is physiologically regulated by presenilin and regulates amyloid β production
The Journal of Cell Biology·2008·300 cit.·DOI
9
Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
Clinical Cancer Research·2015·273 cit.·DOI
10
Characterization of LINE-1 Ribonucleoprotein Particles
PLoS Genetics·2010·245 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.